[an error occurred while processing this directive]

Journal of Chinese Integrative Medicine ›› 2010, Vol. 8 ›› Issue (1): 25-29.doi: 10.3736/jcim20100105

• Original Clinical Research • Previous Articles     Next Articles

Prevention of hospital-acquired pneumonia with Yupingfeng Powder in patients with acute cerebral vascular diseases: A randomized controlled trial

 Li Yana, Xian-chuan Chenb, Jian Guoa, Li-li Qia, Yi-ming Qiana, Xiong-gen Zhoua   

  1. a Department of Emergency, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200437, China
    b Department of Geriatrics, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200437, China
  • Received:2009-07-13 Accepted:2009-10-14 Online:2010-01-20 Published:2010-01-15
  • Contact: Li Yan E-mail:yanli1137@163.com

Background

An increase in the incidence rate of hospital-acquired pneumonia (HAP) has a direct influence on prognosis and survival of patients with acute cerebral vascular diseases (ACVD), and how to prevent HAP is a growing concern to clinicians.
Objective

To study the efficacy of Yupingfeng Powder, a compound traditional Chinese herbal medicine, in preventing HAP in patients with ACVD.
Design, setting, participants and interventions

Sixty ACVD patients with lung qi deficiency syndrome without concurrent infections were randomly divided into prevention group (28 cases) and control group (32 cases). The 60 cases were all from Shanghai Yueyang Hospital of Integrated Traditional Chinese and Western Medicine. Tough measures were taken to prevent cross-infection based on treatment of the primary diseases, well nutrition and support therapy. Yupingfeng Powder was used in the prevention group to prevent HAP. The patients were treated for 10 days.
Main outcome measures

The clinical symptoms, physical signs, body temperature, and chest X-ray were observed. The changes of blood immunoglobulin A (IgA), immunoglobulin G (IgG), immunoglobulin M (IgM) and interleukin-6 (IL-6) were detected before and after treatment.
Results

The total response rate in the prevention group was higher than that in the control group (P<0.05), and the total response rates were 78.57% (22/28) and 31.25% (10/32) respectively. The incidence rate of HAP in the prevention group was lower than that in the control group. There were no significant differences in white blood cell count, neutrophilic granulocyte count, and the levels of IgA, IgG, IgM and IL-6 between the two groups before treatment. The white blood cell count and neutrophilic granulocyte count in the control group increased after treatment, and there was a significant difference between the two groups (P<0.05). There was no significant difference in IgA level in the two groups after treatment, and the IgM levels in the two groups were higher than those before treatment (P<0.05), however there was no significant difference in IgM level between the two groups. In the prevention group, there were significant differences in values of IgG and IL-6 between before and after treatmant (P<0.01), and after treatment there were differences in values of IgG and IL-6 between the two groups (P<0.05).
Conclusion

Yupingfeng Powder has a good clinical effect in prevention of HAP in patients with ACVD, and it can improve the immunological function and relieve the lung qi deficiency symptoms. So the prevention effect of Yupingfeng Powder on HAP is worth being further investigated.

Key words: Brain vascular disorder, Hospital-acquired pneumonia, Prevention, Randomized controlled trial, Chinese herbal drugs

Table 1

General conditions of two groups"

Item Control group
(n=32)
Prevention group
(n=28)
Mean age (x±s, years) 69.13±8.12 68.86±8.33
Sex (Male/Female) 20/12 18/10
Hypertension 15 12
Coronary heart disease 5 4
Type 2 diabetes 7 6
Chronic obstructive pulmonary disease 1 2
Other diseases 4 4
Ischemic stroke/Cerebral hemorrhagic stroke 30/2 26/2
Oral intake/Nasal feed 27/5 24/4

Figure 1

Flow diagram of this randomized trial"

[1] Society of Respiratory Diseases, Chinese Medical Association . Guidelines for the diagnosis and treatment of hospital-acquired pneumonia(Draft)[J]. Zhonghua Jie He He Hu Xi Za Zhi, 1999,22(4):201
中华医学会呼吸病学分会. 医院获得性肺炎诊断和治疗指南(草案)[J]. 中华结核和呼吸杂志, 1999,22(4):201
[2] Kong FB, Zhao Y, Shao FY, Zhao ZX, Zhang LY . Complications in acute stroke patients[J]. Di Er Jun Yi Da Xue Xue Bao, 2000,21(5):459
doi: 10.3321/j.issn:0258-879X.2000.05.035
孔凡斌, 赵瑛, 邵福源, 赵忠新, 张连运 . 急性脑卒中并发症分析[J]. 第二军医大学学报, 2000,21(5):459
doi: 10.3321/j.issn:0258-879X.2000.05.035
[3] Katzan IL, Cebul RD, Husak SH, Dawson NV, Baker DW . The effect of pneumonia on mortality among patients hospitalized for acute stroke[J]. Neurology, 2003,60(4):620-625
doi: 10.1212/01.WNL.0000046586.38284.60 pmid: 12601102
[4] Davenport RJ, Dennis MS, Wellwood I, Warlow CP . Complications after acute stroke[J]. Stroke, 1996,27(3):415-420
doi: 10.1161/01.STR.27.3.415
[5] Deng BM, Xu E, Liang R, Liu ZY, Lu XF . The effects of medical complications on prognosis of the stroke patients[J]. Zhong Feng Yu Shen Jing Ji Bing Za Zhi, 2005,22(1):59-61
doi: 10.3969/j.issn.1003-2754.2005.01.019
邓兵梅, 徐恩, 梁睿, 刘祖佑, 陆雪芬 . 内科并发症对急性脑卒中患者预后的影响[J]. 中风与神经疾病杂志, 2005,22(1):59-61
doi: 10.3969/j.issn.1003-2754.2005.01.019
[6] Feng T, Wang YJ, Qi XK . The relationship between serum thrombomodulin and tumor necrosis factor-α in acute cerebral infarct with HAP[J]. Zhongguo Dong Mai Ying Hua Za Zhi, 2005,13(6):757-759
doi: 10.3969/j.issn.1007-3949.2005.06.022
冯涛, 王拥军, 戚晓昆 . 脑梗死合并肺部感染后血浆血栓调节蛋白与肿瘤坏死因子α的相关性[J]. 中国动脉硬化杂志, 2005,13(6):757-759
doi: 10.3969/j.issn.1007-3949.2005.06.022
[7] Chinese Society of Neuroscience and Chinese Society of Neurosurgery . The diagnostic outlines for different types of cerebrovascular diseases[J]. Zhonghua Shen Jing Ke Za Zhi, 1996,29(6):379-380
中华神经科学会, 中华神外科学会. 各类脑血管疾病诊断要点[J]. 中华神经科杂志, 1996,29(6):379-380
[8] State Food and Drug Administration. Guidelines for clinical research on Chinese new herbal medicines(trial implementation)[M]. Beijing: Medical Science and Technology Publishing House of China, 2002: 298
国家食品药品监督管理局. 中药新药临床研究指导原则(试行)[M]. 北京: 中国医药科技出版社, 200:298
[9] Hamidon BB, Raymond AA . Risk factors and complications of acute ischaemic stroke patients at Hospital Universiti Kebangsaan Malaysia(HUKM)[J]. Med J Malaysia, 2003,58(4):499-505
[10] Hong K . Diagnosis and treatment of medical complications in acute stroke patients[J]. Yi Xue Zong Shu, 2006,10(6):366-368
doi: 10.3969/j.issn.1006-2084.2004.06.021
洪克 . 急性脑卒中常见并发症的诊治[J]. 医学综述, 2006,10(6):366-368
doi: 10.3969/j.issn.1006-2084.2004.06.021
[11] Wang JF, Zhong LZ, Li P, Xie TG, Li Z . Changes of serum IL-10 and Ag-NORs of T lymphocytes in patients with acute cerebral[J]. strokeShen Jing Ji Bing Yu Jing Shen Wei Sheng, 2006,6(2):98-100
doi: 10.3969/j.issn.1009-6574.2006.02.006
王剑锋, 钟丽珍, 李萍, 谢田刚, 李志 . 脑卒中急性期血清白介素-10和外周血T淋巴细胞Ag-NORs的动态变化[J]. 神经疾病与精神卫生, 2006,6(2):98-100
doi: 10.3969/j.issn.1009-6574.2006.02.006
[12] Li ML, Luo ZM . A research on factors influencing the clinical prognosis of acute stroke patients[J]. Hua Xi Yi Xue, 2001,16(3):289-291
doi: 10.3969/j.issn.1002-0179.2001.03.019
李曼丽, 罗祖明 . 影响脑卒中患者临床预后因素的研究[J]. 华西医学, 2001,16(3):289-291
doi: 10.3969/j.issn.1002-0179.2001.03.019
[13] Chang FY, Wang YY . Review on the pathogenesis of stroke[J]. Liaoning Zhong Yi Za Zhi, 2004,31(2):21-23
常富业, 王永炎 . 中风病发病学研究述评[J]. 辽宁中医杂志, 2004,31(2):21-23
[1] Na Wu , Lu Song , Xin-xin Yang, Jiang-lei Wei , Zhen-guo Liu. Effects of Chinese herbal medicine Tianqi Pingchan Granule on G protein-coupled receptor kinase 6 involved in the prevention of levodopa-induced dyskinesia in rats with Parkinson disease. Journal of Chinese Integrative Medicine, 2012, 10(9): 1018-1024.
[2] Jing-lin Shi, Wan-hong Miao. Effects of acupuncture on lactoferrin content in tears and tear secretion in patients suffering from dry eyes: A randomized controlled trial. Journal of Chinese Integrative Medicine, 2012, 10(9): 1003-1008.
[3] Ming T. Tan , Jian-ping Liu , Lixing Lao. Adequate application of quantitative and qualitative statistic analytic methods in acupuncture clinical trials. Journal of Chinese Integrative Medicine, 2012, 10(8): 847-852.
[4] Xin-min Li, Hui Chen, Yan-yan Ren, Yan-li Lu. Effects of Chinese herbal medicine Xifeng Capsule on multidrug resistance-associated protein 1 expression in hippocampus and cortex of rats with lithium-pilocarpine-induced epilepsy. Journal of Chinese Integrative Medicine, 2012, 10(8): 911-917.
[5] Yong Zhang, Xiao-wen Sun, Jian-hua Xu, Hai Lu, Zhong-ze Fan, Jue Sun, Xiao-xiao Zhang. Effects of medicated serum prepared with Chinese herbal medicine Changweiqing on pharmacokinetics of oxaliplatin in colon cancer cells. Journal of Chinese Integrative Medicine, 2012, 10(8): 901-910.
[6] Wei-hua Xu, Ze-huai Wen, Wei-xiong Liang, Qi Wang. A review of research on the development of instruments for therapeutic efficacy evaluation of traditional Chinese medicine. Journal of Chinese Integrative Medicine, 2012, 10(7): 726-737.
[7] Lin Wang, Guan-liang Wang, Jia-han Liu, Di Li, De-zeng Zhu, Liang-neng Wu . Effects of ursolic acid in ameliorating insulin resistance in liver of KKAy mice via peroxisome proliferator-activated receptors α and γ. Journal of Chinese Integrative Medicine, 2012, 10(7): 793-799.
[8] Lu Yu, Shui-miao Lin, Ru-qian Zhou, Wei-jun Tang, Pin-xian Huang, Ying Dong, Jian Wang, Zhi-hua Yu, Jiu-lin Chen, Li Wei, San-li Xing, Hui-juan Cao, Hong-bin Zhao. Chinese herbal medicine for patients with mild to moderate Alzheimer disease based on syndrome differentiation: A randomized controlled trial. Journal of Chinese Integrative Medicine, 2012, 10(7): 766-776.
[9] Hui Luo, Jian-ping Liu, Qing Li. Methodological issues and suggestions for improvement in randomized controlled trials of Chinese herbal medicine for recurrent miscarriage. Journal of Chinese Integrative Medicine, 2012, 10(6): 604-614.
[10] Peng Fu , Xue-qiang Huang, Ai-hong Yuan, Guang Yu, Xiao-bin Mei, Ruo-lan Cu. Effects of salvianolate combined with alprostadil and reduced glutathione on progression of chronic renal failure in patients with chronic kidney diseases: a long-term randomized controlled trial. Journal of Chinese Integrative Medicine, 2012, 10(6): 641-646.
[11] Shui-qiu Deng, Xue-nong Ouyang, Zong-yang Yu, Xi-hu Dai, Xi Chen, Fang-zheng Fang, Wen-wu Wang, Zhi-zhen Liu. Influence of Chinese herbal medicine Feitai Capsule on completion or delay of chemotherapy in patients with stage ⅢB/Ⅳ non-small-cell lung cancer: a Randomized controlled trial. Journal of Chinese Integrative Medicine, 2012, 10(6): 635-640.
[12] Ming-xing Zhao, Zhen-hua Dong, Zhong-hai Yu, Shi-yuan Xiao, Ya-ming Li . Effects of Ginkgo biloba extract in improving episodic memory of patients with mild cognitive impairment: A randomized controlled trial. Journal of Chinese Integrative Medicine, 2012, 10(6): 628-634.
[13] Ying-chun Miao , Jin-zhou Tian , Jing Shi , Min Mao. Effects of Chinese medicine for tonifying the kidney and resolving phlegm and blood stasis in treating patients with amnestic mild cognitive impairment: A randomized, double-blind and parallel-controlled trial. Journal of Chinese Integrative Medicine, 2012, 10(4): 390-397.
[14] Xiao-hui Sun, Sheng Liu . External Chinese medical therapy for pain associated with hyperplastic disease of the breast: Study protocol of a randomized, double-blind, multicenter, controlled trial. Journal of Chinese Integrative Medicine, 2012, 10(4): 384-389.
[15] Zhu Yan-feng, Luo Hai-ming, Deng Zhong-long, Fu De-yu, Yao Wang, Dai Jian. Effects of the Chinese patent medicine, Honghua Injection, on platelet glycoprotein Ⅱb/Ⅲa receptors in patients with acute coronary syndrome: a randomized controlled trial. Journal of Chinese Integrative Medicine, 2012, 10(3): 318-323.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] Dong Yang, Yong-ping Du, Qing Shen, Wei Chen, Yan Yu, Guang-lei Chen. Expression of alpha-smooth muscle actin in renal tubulointerstitium in patients with kidney collateral stasis. Journal of Chinese Integrative Medicine, 2008, 6(1): 41-44
[2] Hai-feng Wei, Bai-liu Ya, Ling Zhao, Cui-fei Ye, Li Zhang, Lin Li. Evaluation of tongue manifestation of blood stasis syndrome and its relationship with blood rheological disorder in a rat model of transient brain ischemia. Journal of Chinese Integrative Medicine, 2008, 6(1): 73-76
[3] Xi Lin, Jian-ping Liu. Herbal medicines for viral myocarditis. Journal of Chinese Integrative Medicine, 2008, 6(1): 76
[4] Xi Lin, Jian-ping Liu. Tai chi for treating rheumatoid arthritis. Journal of Chinese Integrative Medicine, 2008, 6(1): 82
[5] Liang-ping Hu, Hui Gao. Discrimination of errors in statistical analysis of medical papers published in the first issue of 2006 in Journal of Chinese Integrative Medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 98-106
[6] Yan-bo Zhu , Qi Wang, Cheng-yu Wu, Guo-ming Pang, Jian-xiong Zhao, Shi-lin Shen, Zhong-yuan Xia , Xue Yan . Logistic regression analysis on relationships between traditional Chinese medicine constitutional types and overweight or obesity. Journal of Chinese Integrative Medicine, 2010, 8(11): 1023-1035
[7] Wei Xu, Meng Shi, Jian-gang Liu, Cheng-long Wang . Collagen protein expressions in ischemic myocardium of rats with acute myocardial infarction and effects of qi-tonifying, yin-tonifying and blood-activating herbs and detoxifying and blood-activating herbs. Journal of Chinese Integrative Medicine, 2010, 8(11): 1041-1047
[8] Tao Wang , Feng Qin. Effects of Chinese herbal medicine Xiaoyao Powder on monoamine neurotransmitters in hippocampus of rats with postpartum depression. Journal of Chinese Integrative Medicine, 2010, 8(11): 1075-1079
[9] Ying Xu , Chang-chun Zeng , Xiu-yu Cai , Rong-ping Guo , Guang Nie , Ying Jin. Chromaticity and optical spectrum colorimetry of the tongue color in different syndromes of primary hepatic carcinoma. Journal of Chinese Integrative Medicine, 2012, 10(11): 1263-1271
[10] Xiang-ying Mao , Qin Bian , Zi-yin Shen. Analysis of the osteogenetic effects exerted on mesenchymal stem cell strain C3H10T1/2 by icariin via MAPK signaling pathway in vitro. Journal of Chinese Integrative Medicine, 2012, 10(11): 1272-1278
[an error occurred while processing this directive]